₹0.36
(Market cap
₹886 Cr
Recently Viewed
Clear AllMarket cap
₹886 Cr
Revenue (TTM)
₹40 Cr
P/E Ratio
94.1
P/B Ratio
3.1
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹10 Cr
ROE
68.6 %
ROCE
63 %
Industry P/E
47.98
EV/EBITDA
53.7
Debt to Equity
0.1
Book Value
₹4.6
EPS
₹1.7
Face value
2
Shares outstanding
78,843,250
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Gujarat Kidney And Super Speciality
| 9.2 | 10.5 | 13.2 | -- | -- | -- | -- |
|
BSE Healthcare
| 0.4 | 5.5 | 5.6 | 2.2 | 24.1 | 13.3 | 10.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Gujarat Kidney And Super Speciality
|
112.4 | 886.2 | 40.2 | 9.5 | -- | 68.6 | 94.1 | 3.1 |
| 705.3 | 36,548.3 | 4,461.2 | 397.5 | 13.4 | 9.1 | 111.8 | 7.9 | |
| 438.1 | 13,881.2 | 1,976.2 | 160.7 | 14.1 | 6.7 | 110.1 | 7.0 | |
| 569.4 | 8,496.0 | 2,478.2 | 24.7 | 8.4 | 4.2 | 448.3 | 6.4 | |
| 406.5 | 3,719.2 | 1,451.5 | 182.9 | 15.5 | 29.2 | 20.3 | 5.3 | |
| 1,247.2 | 8,156.1 | 1,433.4 | 188.7 | 17.4 | 13.8 | 43.2 | 5.5 | |
| 5,659.6 | 6,171.9 | 1,529.9 | 235.8 | 21.2 | 20.7 | 26.2 | 4.9 | |
| 232.7 | 10,025.1 | 1,393.6 | 213.2 | -- | 22.1 | 48.9 | 5.3 | |
| 1,242.3 | 12,568.5 | 1,613.3 | 259.9 | 23.0 | 17.3 | 48.8 | 7.9 | |
| 718.3 | 6,930.3 | 1,089.4 | 165.1 | 17.4 | 10.2 | 41.4 | 4.0 |
No Review & Analysis are available.
--
Incorporated
2019
Chairman
Pragnesh Yashwantsinh Bharpoda
Managing Director
Pragnesh Yashwantsinh Bharpoda
Headquarters
Vadodara, Gujarat
Website
Looking for more details about Gujarat Kidney And Super Speciality Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Gujarat Kidney And Super Speciality Ltd is ₹112.44 (NSE) and ₹112.40 (BSE) as of 24-Apr-2026 IST. Gujarat Kidney And Super Speciality Ltd has given a return of --% in the last 1 years.
The P/E ratio of Gujarat Kidney And Super Speciality Ltd is 94.15 times as on 24-Apr-2026, a 96 premium to its peers’ median range of 47.98 times.
The P/B ratio of Gujarat Kidney And Super Speciality Ltd is 3.08 times as on 24-Apr-2026, a 53 discount to its peers’ median range of 6.56 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
The 52-week high and low of Gujarat Kidney And Super Speciality Ltd are Rs 123.00 and Rs 98.36 as of 24-Apr-2026.
Gujarat Kidney And Super Speciality Ltd has a market capitalisation of ₹ 886 Cr as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Gujarat Kidney And Super Speciality Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.